

Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Centerview Partners LLC."
12 result(s) displayed (1 - 12 of 14)
The new $3.40 per share offer tops a rival bid of $3.30 a share by Dish Network. Continue reading
Posted on May 21, 2013 1:04 PM
Elan cedes control of the blockbuster multiple sclerosis drug, its sole revenue producer, in an attempt to pursue a new strategic direction through acquisitions. Continue reading
Posted on February 6, 2013 11:23 AM
The drugmaker will acquire MAP Pharmaceuticals in deal that values the target's equity at $958 million, giving analysts who follow the buyer an aching head. Continue reading
Posted on January 23, 2013 4:20 PM
Minority shareholders still want to see more but with the target's other telecom shareholders backing the deal, their protest may fall on deaf ears. Continue reading
Posted on December 17, 2012 10:59 AM
The St. Louis private label food company rejected a $7.4 billion bid last year, spun off Post. Continue reading
Posted on November 27, 2012 10:04 AM
Rupert Murdoch will serve as chairman of both entities and head the more profitable media and entertainment company. Continue reading
Posted on June 28, 2012 10:31 AM
But Boeing CEO James McNerney also says he'll support a consensual merger, if one emerges Continue reading
Posted on April 25, 2012 3:46 PM
Nestlé triumphs over Danone with a bid valuing the business at 19.8 times forecast Ebitda Continue reading
Posted on April 23, 2012 10:28 AM
The TV ratings company prices a 30 million share offering by majority owners at $30.25 apiece, raising about $907.5 million Continue reading
Posted on March 21, 2012 2:00 PM
Negotiations added $3 billion to the search giant's original offer. Continue reading
Posted on September 15, 2011 10:01 AM
A conversation with RBC's Justin Mirro, dispensing advice at Rothschild, structuring restructuring at Centerview, and a power alley for Wells Fargo. Continue reading
Posted on July 22, 2011 1:01 PM
In the wake of the Delaware judge's scolding in Del Monte, KKR avoids Morgan Stanley's financing on Capsugel. Is this just sensitivity or a trend? Continue reading
Posted on April 25, 2011 12:45 PM
Movable Type search results powered by Fast Search